Sub-Retinal Administration of OCU400-301

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis PigmentosaNCT06388200OcugenPhase 3Active not recruiting2027-02-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.